These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 15776232)

  • 1. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
    Schöder H; Campisi R; Ohtake T; Hoh CK; Moon DH; Czernin J; Schelbert HR
    J Am Coll Cardiol; 1999 Apr; 33(5):1328-37. PubMed ID: 10193735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications.
    Tavares de Melo MD; Giorgi MCP; Assuncao AN; Dantas RN; Araujo Filho JA; Parga Filho JR; Bierrenbach ALS; de Lima CR; Soares J; Meneguetti JC; Mady C; Hajjar LA; Kalil Filho R; Bocchi EA; Salemi VMC
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):915-921. PubMed ID: 28379356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
    Tsai SY; Wu YW; Wang SY; Shiau YC; Chiu KM; Tsai HY; Lee CL; Hsu JC; Tu CM; Lin HH; Huang SH
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2601-2609. PubMed ID: 31410543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure.
    Mielniczuk LM; Birnie D; Ziadi MC; deKemp RA; DaSilva JN; Burwash I; Tang AT; Davies RA; Haddad H; Guo A; Aung M; Williams K; Ukkonen H; Beanlands RS
    Circ Cardiovasc Imaging; 2011 Jan; 4(1):59-66. PubMed ID: 21057116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; de Boer J; Jager PL
    J Nucl Cardiol; 2006; 13(2):210-9. PubMed ID: 16580957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
    Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
    Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability.
    Mélon PG; de Landsheere CM; Degueldre C; Peters JL; Kulbertus HE; Piérard LA
    J Am Coll Cardiol; 1997 Dec; 30(7):1651-9. PubMed ID: 9385890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
    Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Reinartz P; Buecker A; Krombach GA; Buell U; Kühl HP
    J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of myocardial glucose metabolism before and after recovery of myocardial function in patients with tachycardia-induced cardiomyopathy.
    Matsumoto K; Takahashi N; Ishikawa T; Sumita S; Matsushita K; Inoue N; Kobayashi T; Uchino K; Kimura K; Inoue T; Umemura S
    Pacing Clin Electrophysiol; 2006 Feb; 29(2):175-80. PubMed ID: 16492304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET.
    Khorsand A; Graf S; Eidherr H; Wadsak W; Kletter K; Sochor H; Schuster E; Porenta G
    J Nucl Med; 2005 Dec; 46(12):2009-13. PubMed ID: 16330564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gated fluorine 18 fluorodeoxyglucose positron emission tomography: determination of global and regional left ventricular function and myocardial tissue characterization.
    Saab G; Dekemp RA; Ukkonen H; Ruddy TD; Germano G; Beanlands RS
    J Nucl Cardiol; 2003; 10(3):297-303. PubMed ID: 12794629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
    Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
    Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
    Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
    J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
    Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
    Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring left ventricular dilation in mice with PET.
    Stegger L; Schäfers KP; Flögel U; Livieratos L; Hermann S; Jacoby C; Keul P; Conway EM; Schober O; Schrader J; Levkau B; Schäfers M
    J Nucl Med; 2005 Sep; 46(9):1516-21. PubMed ID: 16157535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
    Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
    J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.